Gossamer Bio (GOSS) Reports Topline Phase 3 Results for Seralutinib in Pulmonary Arterial Hypertension

Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best penny stocks under $1 to buy right now. On February 23, Gossamer Bio ...

Where is Nuvation Bio Inc. (NUVB) Headed According to Wall Street Analysts?

Nuvation Bio Inc. (NYSE:NUVB) is one of the best small-cap stocks with huge growth potential. Nuvation Bio Inc. (NYSE:NUVB) announced on February 9 the finalization of a protocol amendment to the ...

Gossamer Bio plans FDA talks after narrow miss in key pivotal study, stock sinks

Gossamer Bio Inc. GOSS dropped during early trading on Monday after the company shared topline results from the Phase 3 PROSERA study evaluating seralutinib in pulmonary arterial hypertension. PAH is ...

Tevogen Bio Inc: Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter ...

Tevogen Bio Inc: Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus

Tevogen ("Tevogen Bio Holdings Inc.") (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding ...
American Association of Individual Investors

Why ImmunityBio, Inc.’s (IBRX) Stock Is Down 7.02%

As of Friday, February 27, ImmunityBio, Inc.’s IBRX share price has dipped by 7.02%, which has investors questioning if this is right time to buy.